MAP microba life sciences limited

News: MAP Microba Life Sciences Says Q4 FY23 Unaudited Revenue Totalled A$2.25M

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    July 27 (Reuters) - Microba Life Sciences Ltd (MAP) :

    • Q4 FY23 UNAUDITED REVENUE TOTALLED A$2.25M, UP 21.5% YOY
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.6¢
Change
-0.001(1.03%)
Mkt cap ! $58.46M
Open High Low Value Volume
9.8¢ 9.8¢ 9.5¢ $28.61K 295.4K

Buyers (Bids)

No. Vol. Price($)
3 74000 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 74800 3
View Market Depth
Last trade - 15.47pm 22/08/2025 (20 minute delay) ?
MAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.